Online Slide/Audio Symposium

		Basic Nephrology Lecture Series May, 1998 IgA Nephropathy Symposium supported by educational grants from the National Kidney Foundation of Texas and in cooperation with the IgA Nephropathy Foundation.
IgA Nephropathy
From October 28 - November 30, 1999, these talks will be in the FREE ZONE. You need to be a registered user of HDCN. To register for the FREE ZONE of HDCN click here. After November 30, 1999, you will need to have a PAID SUBSCRIPTION to HDCN to access these talks.
The Talks

Clinical Features and Prognostic Indicators of IgA Nephropathy Ronald J. Hogg, M.D. What is IgA Nephropathy and Henoch Schönlein Purpura? J. Charles Jennette, M.D. Evolution of Treatment for IgA Nephropathy Bryson Waldo, M.D. Omega-3 and IgA Nephropathy James V. Donadio, Jr., M.D. Role of ACE Inhibitors in the Management of IgA Nephropathy Daniel C. Cattran, M.D. Pathologic Features and How They Impact Diagnosis Richard K. Sibley, M.D.

Daniel C. Cattran, M.D. Professor of Medicine, University of Toronto, Toronto, Ontario, Canada. James V. Donadio, Jr., M.D. Chair Emeritus of the Division of Nephrology at the Mayo Clinic in Rochester. Founded the Mayo Nephrology Collaborative group. Ronald J. Hogg, M.D. Director of Pediatric Nephrology, Medical City Dallas Hospital, Dallas, TX. Director, Southwest Pediatric Nephrology Study Group. J. Charles Jennette, M.D. Professor of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, NC. Richard K. Sibley, M.D. Professor of Pathology and Co-Director, Surgical Pathology Laboratory, Stanford University, San Francisco, CA. Bryson Waldo, M.D. Pediatric Nephrologist, Birmingham, AL.

Back to symposia list by topic
Back to symposia list by meeting
Back to HDCN home page